{"name": "Onyvax",
 "permalink": "onyvax",
 "crunchbase_url": "http://www.crunchbase.com/company/onyvax",
 "homepage_url": "http://www.onyvax.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Apr 22 12:24:15 UTC 2010",
 "updated_at": "Thu Apr 22 12:31:58 UTC 2010",
 "overview": "\u003Cp\u003EOnyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax\u0026#8217;s products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       47],
      "assets/images/resized/0008/4586/84586v1-max-150x150.jpg"],
     [[210,
       66],
      "assets/images/resized/0008/4586/84586v1-max-250x250.jpg"],
     [[210,
       66],
      "assets/images/resized/0008/4586/84586v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a38M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.onyvax.com/html/press_releases/1/2006_05_08_Fundraising.html",
    "source_description": "Onyvax Raises \u00c2\u00a38 Million to Advance Development of Prostate Cancer Vaccine",
    "raised_amount": 8000000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "3i Group",
         "permalink": "3i-group",
         "image":
          {"available_sizes":
            [[[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-150x150.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-250x250.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Merlin Biosciences",
         "permalink": "merlin-biosciences",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MB Venture Capital Fund",
         "permalink": "mb-venture-capital-fund",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0010/2652/102652v1-max-150x150.jpg"],
             [[238,
               48],
              "assets/images/resized/0010/2652/102652v1-max-250x250.jpg"],
             [[238,
               48],
              "assets/images/resized/0010/2652/102652v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Berkeley Venture Partners",
         "permalink": "alta-berkeley-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0009/9813/99813v1-max-150x150.png"],
             [[178,
               33],
              "assets/images/resized/0009/9813/99813v1-max-250x250.png"],
             [[178,
               33],
              "assets/images/resized/0009/9813/99813v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Tong Hall, Tong",
    "address2": "Bradford",
    "zip_code": "BD4 0RR",
    "city": "West Yorkshire",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        83],
       "assets/images/resized/0008/4587/84587v1-max-150x150.jpg"],
      [[250,
        139],
       "assets/images/resized/0008/4587/84587v1-max-250x250.jpg"],
      [[450,
        250],
       "assets/images/resized/0008/4587/84587v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}